Olbia, Italy's first AI spinal cord neurostimulation implant

At the private hospital Mater Olbia is the first implantation of a device in Italy has been carried out high frequency spinal cord neurostimulation using Artificial intelligence for medical purposes: this is the latest generation of the high frequency SCS device of the line Neuro for the treatment of chronic pain. The Nevro HFXiQ high-frequency spinal cord neurostimulator is capable of exploiting new medical applications of artificial intelligence to ensure better and adequate management of chronic pain improving quality of the patient's life. After an experimental phase carried out in three pilot centers in Verona, Ravenna and Naples, Mater Olbia is the first center Italian to have officially implanted this new type of device. "We are proud to announce that it has been performed with successful first implant of the HFXiQ device after the centers involved since the Limited Market Release phase - says Paolo Cossu, head of the Intensive Care Anesthesia department and pain therapy - This technology opens up scenarios so far unimaginable for the management of chronic pain, since thanks to With AI we can adapt the stimulation without the need for frequent outpatient visits, reducing inconvenience for the patient and increasing the precision of the intervention therapeutic." The system allows a completely different level of interaction new between the patient and the neurostimulator, thanks to the integration of artificial intelligence algorithms. The patient can communicate with the device via a advanced remote control, similar to a latest smartphone generation, entering data and receiving in return a personalized stimulation adjustment, in real time and remotely.